The dance between the injunction halting federal support for human embryonic stem cell research and the stay of that injunction continues. On Tuesday the Court of Appeals issued a new stay of the injunction, which will last as long as necessary for that Court to decide whether or not to overturn the injunction.
I cautioned earlier about attempting to guess future decisions from questions in court hearings, so this next bit of speculation should be taken with a little bit of judicial salt.
By granting this medium-term stay, it would seem that the Court anticipates taking a bit of time with its decision. Alternatively, the Court seems to recognize the interests of those affected by the injunction and was trying to give them as much certainty as possible about the current state of federal dollars in this area. I’m more inclined to go with the former explanation, but I am neither a lawyer nor a dedicated court analyst.
Meanwhile, back at the District Court where the lawsuit is being adjudicated, there have been some interesting developments. As Nature notes, the government has filed a motion for summary judgment – asking the judge to decide the case without further courtroom proceedings. The plaintiffs did the same thing earlier this month.
